{
  "catalogId": "97b443a3-b2ac-4d04-bd2b-5297bbb7c0fb",
  "name": "EBGLYSS",
  "status": "draft",
  "category": "prescription",
  "registrationValidity": "valid",
  "registrationNumber": "177 68 38066 00",
  "treatmentDescriptions": "Ebglyss is indicated for the treatment of moderate-to-severe atopic dermatitis in adults and adolescents 12 years and older with a body weight of at least 40 kg who are candidates for systemic therapy.",
  "termsOfIssue": "Prescription required",
  "form": "solution for injection",
  "route": "s.c",
  "site": "",
  "method": "",
  "administrationNotes": "",
  "ingredients": "LEBRIKIZUMAB/ML",
  "codes": {
    "atc5": {
      "system": "WHO ATC Classification",
      "code": "D11AH10",
      "name": "LEBRIKIZUMAB"
    }
  },
  "contraindications": "",
  "sideEffect": "",
  "warnings": "",
  "alternativeMedications": [],
  "packaging": [
    {
      "name": "EBGLYSS 125MG/ML 1 PFP 2 ML",
      "manufacturer": {
        "name": "אלי לילי",
        "countryOfOrigin": "IL"
      },
      "strength": [],
      "quantity": {
        "value": 1.0,
        "unit": "units"
      },
      "packagingDescription": "PRE-FILLED PEN GLASS TYPE I",
      "shelfLife": "24",
      "storageConditions": "",
      "codes": {
        "moh": "9611",
        "barcode": "7290016021523"
      },
      "manufacturersAdministrationRecommendation": "",
      "pricing": {
        "currency": "ILS",
        "maxWholesalePrice": 4352.326414,
        "retailMargin": 10.0,
        "maxRetailPrice": 4787.559055,
        "maxPriceWithVAT": 5649.319434
      },
      "formulation": ""
    }
  ],
  "metadata": {
    "version": "1.5",
    "lastUpdated": "2025-08-01T18:03:53.235812"
  }
}